Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
about
Booster dose vaccination for preventing hepatitis BA Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface AntigenAntibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose.A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines.Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedulesResponse to booster doses of hepatitis B vaccine among young adults who had received neonatal vaccination.Age-specific prevalence of hepatitis B virus infection in young pregnant women, Hong Kong Special Administrative Region of China.Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.The current economic burden of cirrhosis.Persistence of HBV Vaccine's Protection and Response to Hepatitis B Booster Immunization in 5- to 7-Year-Old Children in the Kohgiloyeh and Boyerahmad Province, Iran.Age-dependent decrease of anti-HBs titers and effect of booster doses using 2 different vaccines in Palestinian children vaccinated in early childhood.Effectiveness of hepatitis B virus vaccination program in Egypt: Multicenter national project.Serologic control against hepatitis B virus among dental students of the University of Granada, Spain.Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers.Comparison of long-term immunogenicity (23 years) of 10 μg and 20 μg doses of hepatitis B vaccine in healthy children.An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy.Immune persistence after hepatitis B vaccination in infancy - Fact or fancy?Antibody and immune memory persistence post infant hepatitis B vaccination.Potential role of killer immunoglobulin receptor genes among individuals vaccinated against hepatitis B virus in Lebanon.Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand.Long-term persistence of immunity after vaccination of pre-adolescents with low doses of a recombinant hepatitis B vaccinePredictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine.Personalized cancer immunotherapy using Systems Medicine approaches.Racial/ethnic disparities in the prevalence and awareness of Hepatitis B virus infection and immunity in the United States.Persistence of protection of hepatitis B vaccine and response to booster immunization in 2- to 12-year-old children.Insulin resistance increases loss of antibody to hepatitis B surface antigen in nondiabetic healthy adults.Nosocomial outbreak of hepatitis B virus infection in a pediatric hematology and oncology unit in South Africa: Epidemiological investigation and measures to prevent further transmission.Impact of neonatal hepatitis B vaccination programme on age-specific prevalence of hepatitis B infection in teenage mothers in Hong Kong.Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil.Presence of maternal anti-HBs antibodies does not influence hepatitis B vaccine response in Brazilian neonates.Low hepatitis B immunogenicity of a hexavalent vaccine widely used in Germany: results of the German Health Survey for Children and Adolescents, 2003-2006.Persistence of antibody to hepatitis B surface antigen among vaccinated children in a low hepatitis B virus endemic area.Anti-HBs levels among children and adolescents with complete immunization schedule against hepatitis B virus. A cross-sectional study in Blumenau, State of Santa Catarina, Brazil, 2007-2008.Changes and analysis of anti-HBs titres after primary immunization in 1- to 16-year-old Chinese children: A hospital-based study.High prevalence of hepatitis B-antibody loss and a case report of de novo hepatitis B virus infection in a child after living-donor liver transplantation.High prevalence of hepatitis B-antibody loss and a case report of de novo hepatitis B virus infection in a child after living-donor liver transplantation.Relationship between age and prevalence of hepatitis B infection in first-year university students in Hong Kong.From Infancy and Beyond… Ensuring a lifetime of hepatitis B virus (HBV) vaccine-induced immunity.Hepatitis B At-Birth Dose Vaccine: An Urgent Call for Implementation in Ghana.Correlation between maternal hepatitis B surface antigen carrier status with social, medical and family factors in an endemic area: have we overlooked something?
P2860
Q24236587-3E4747D4-7A0B-43D9-A452-513F89F6CFC3Q30152118-4381F5CD-37BC-41F6-927E-AB51DCD6B848Q30196893-11A7AEB8-FB73-4B97-84BE-8583D99BA888Q33355656-2F3311A5-DDA5-42E3-909E-93B9C9B6D8BEQ34021203-45F6DE17-D5FF-48EB-ACCE-5075912F80DCQ34150102-92E7BAC0-6D14-4E15-8437-BCAC90AC8337Q34460388-A11DDF12-F891-4C37-8E81-62EEFDDBE359Q35055166-E66A6A82-BCF8-48B2-8CFF-0651063A35C1Q35691411-2713DCD3-F5A9-4F95-8CA0-8557E3F2B227Q35724470-54FC16CD-4FBD-4525-A44B-EC78E9E125DCQ35887238-6E1F93B1-9861-4DA2-BED5-48D76DBFE113Q36138640-97FECDC0-7212-455F-9D4A-1B4B75C481BAQ36139577-880DA2F1-9CF1-4F6A-90CF-1C6E3ADDD4A7Q36391894-EBBC410F-FC73-42C6-A087-059CCFD6915FQ36552883-D7FF15BE-D208-436C-9AEE-3CEB4CAEDA51Q36838969-71BDB065-E9B3-4CAC-A9F0-EE796F77835FQ37131019-0362A1F3-8649-4749-86DB-FFB1D33EFB5DQ37216022-D3D30FE1-9078-4E97-9A6A-AE1756228635Q37345255-D46D7003-EAF8-471C-B59D-02D8550B8823Q37530077-00BAE806-6B73-479D-8522-8A8CE7B21FDFQ37530082-F9FD58B9-7D0A-499B-B5B4-2EE1C9381C56Q37605957-68D9D88D-6432-4E75-9BF3-E49F8C529DACQ38547040-51B0334A-4395-4BBC-8201-5218586675FCQ38743832-BEC85591-4A63-417F-8C42-46089395AAA1Q40057020-36096905-956A-40B7-A9B0-2B4E41667A7EQ40471500-24933F3A-C9BD-45C9-96F0-2E14E877E9EEQ41182375-28DC3FE8-CFB3-4B76-ABD4-4B7997960D24Q42283868-03EFF777-867B-4D4D-B5BE-2D0BB2C5A0EBQ43037024-7495DE67-2CAA-4ABD-9061-A4F842AED253Q43751910-2158602C-15A2-44C5-91BE-95D890358A1BQ44525165-F8AEAAF0-1E47-4770-8B27-EECC81071C7FQ45363795-D88FA8F4-4D0D-44DF-A658-8B408F4F00BBQ45364703-81EC42D2-7D10-40CB-A48C-C0AD99DF6278Q47229194-E1EE26A9-EBCC-4852-8ED1-18BED7D1A276Q49741477-59B25664-04C4-4BBC-B7D4-31AE2BCB38A4Q49885440-A498220F-C989-4164-A910-C1E5458B2398Q50889232-9836DEF2-61CC-407C-85CA-8BF468CA89ECQ52594315-CE1999C2-B94B-4C3B-9D45-FF6DE492FDC0Q54256725-3109C74D-DC50-4C06-967B-FBF5D2E302E9Q58029018-4C4C5DBF-2589-4B0F-9B64-099081B78BC0
P2860
Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Hepatitis B immunity in childr ...... a follow-up study at 15 years.
@en
Hepatitis B immunity in childr ...... a follow-up study at 15 years.
@nl
type
label
Hepatitis B immunity in childr ...... a follow-up study at 15 years.
@en
Hepatitis B immunity in childr ...... a follow-up study at 15 years.
@nl
prefLabel
Hepatitis B immunity in childr ...... a follow-up study at 15 years.
@en
Hepatitis B immunity in childr ...... a follow-up study at 15 years.
@nl
P2093
P1433
P1476
Hepatitis B immunity in childr ...... a follow-up study at 15 years.
@en
P2093
Anthony E Fiore
Brian J McMahon
Carolyn Zanis
Eitel Dunaway
Kimberlee Boyd Hummel
Laura L Hammitt
Lisa Bulkow
P304
P356
10.1016/J.VACCINE.2007.06.059
P407
P577
2007-07-17T00:00:00Z